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Abstract
Complicated intra-abdominal infections are frequently associated with poor prognoses and high morbidity and
mortality rates.
Despite advances in diagnosis, surgery, and antimicrobial therapy, mortality rates associated with complicated intra-
abdominal infections remain exceedingly high.
In order to describe the clinical, microbiological, and management-related profiles of both community-acquired
and healthcare-acquired complicated intra-abdominal infections (IAIs), the World Society of Emergency Surgery
(WSES), in collaboration with the Surgical Infections Society of Europe (SIS-E) and other prominent European
surgical societies, has designed the CIAO study.
The CIAO study is a multicenter, observational study and will be carried out in various surgical departments
throughout Europe. The study will include patients undergoing surgery or interventional drainage for complicated
IAI.
Background
Intra-abdominal infections (IAIs) include a wide array of
pathological conditions, ranging from uncomplicated
appendicitis to fecal peritonitis.
From a clinical perspective, IAIs are classified in two
distinct groups: uncomplicated and complicated infec-
tions [1].
In uncomplicated IAIs, the infectious process involves
only a single organ and does not extend to the perito-
neum. Patients with uncomplicated infections can be
treated surgically by means of resection or non-opera-
tively with antibiotic therapy. When the focus of infec-
tion is effectively treated by surgical excision, 24-hour
perioperative prophylaxis is typically sufficient. Patients
with intra-abdominal infections, including acute diverti-
culitis and certain forms of acute appendicitis, may be
managed non-operatively.
In complicated IAIs, the infectious process extends
beyond a singly affected organ, and causes either loca-
lized peritonitis (intra-abdominal abscess), or diffuse
peritonitis. The treatment of patients with complicated
intra-abdominal infections involves both source control
and antibiotic therapy.
Intra-abdominal infections are further classified as
either community-acquired intra-abdominal infections
(CA-IAIs) or healthcare-associated intra-abdominal
infections (HA-IAIs). CA-IAIs, as the name implies, are
acquired directly in the community while HA-IAIs
develop in hospitalized patients or residents of long-
term healthcare facilities. Of the two, the latter is asso-
ciated with higher rates of mortality due to the patients’
poorer underlying health and an increased likelihood of
infection by multi-drug resistant microorganisms [2].
Source control encompasses all measures undertaken
to eliminate the source of infection and control ongoing
contamination [3].
The appendix is the most common source of infection
in community-acquired intra-abdominal infections, fol-
lowed closely by the colon and stomach. Dehiscences
complicate 5-10% of intra-abdominal bowel anasto-
moses, and are associated with increased mortality rates
[4].
Control of the septic source can be achieved by both
operative and non-operative means.
Non-operative interventional procedures involve the
percutaneous drainage of abscesses.
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abdominal and extra-peritoneal abscesses have proven
to be safe and effective in select patients [5-12].
Surgery is the most important therapeutic recourse for
controlling intra-abdominal infections.
Patients suffering from severe peritonitis are prone to
persisting intra-abdominal infection, even when the
source of infection has been neutralized. In these cases,
timely re-laparotomy is the only surgical recourse
known to significantly improve patient outcome.
Additionally, it should be pointed out that a single
procedure may not suffice, and further surgical explora-
tion may be necessary to achieve adequate source con-
trol [13-16].
In the event of secondary peritonitis, deciding whether
a re-laparotomy is the proper course of action, and if so,
when the procedure should be performed, is largely sub-
jective and often based on a surgeon’s professional
experience. Factors indicative of progressive or persis-
tent organ failure during early postoperative follow-up
analysis are the strongest indicators of ongoing infection
and suggest positive findings upon re-laparotomy
[17-19].
Three methods of localized, mechanical management
of abdominal sepsis following the initial laparotomy,
which was performed for purposes of source control,
are currently debated within the medical community:
(1) Open-abdomen
(2) Planned re-laparotomy,
(3) On-demand re-laparotomy
In 2007, van Ruler et al. [20] published the findings of
a randomized, clinical trial comparing on-demand and
planned re-laparotomies for patients with severe
peritonitis.
During the course of the trial, a total of 232 patients
with severe intra-abdominal infections (116 planned and
116 on-demand) were randomized.
In the planned re-laparotomy group, re-laparotomies
were performed every 36 to 48 hours following the
index laparotomy to inspect, drain, lavage, and perform
other necessary abdominal interventions for residual
peritonitis or newly established focal infections.
In the on-demand re-laparotomy group, re-laparo-
tomies were only performed on those patients demon-
strating clinical deterioration or lack of clinical
improvement due to intra-abdominal pathology.
Patients in the on-demand re-laparotomy group failed
to demonstrate a statistically significant decrease in the
rate of adverse treatment outcomes compared to
patients in the planned re-laparotomy group, but these
patients did feature a substantial reduction in re-laparo-
tomies, general health care utilization, and overall medi-
cal costs.
Antimicrobial therapy also plays an integral role in the
management of intra-abdominal infections; indeed, to
ensure optimal patient outcome, empiric antibiotic ther-
apy should be initiated as early as possible. The misuse
of antibiotic regimens (by administering inappropriate
antimicrobial agents, for example), is perhaps the stron-
gest predictor of unfavorable treatment outcome
[21-24].
The initial antibiotic therapy for IAIs is usually
empiric given that the patient is often critically ill and
microbiological data (culture and susceptibility results)
can take a minimum of 48 hours to become available.
Empiric antibiotic therapy considers the most fre-
quently isolated germs as well as any local trends of
antibiotic resistance.
The major pathogens involved in community-acquired
intra-abdominal infections are Enterobacteriaceae and
anaerobic microbes (especially B. fragilis).
Bacterial drug resistance has become a very serious
problem, particularly given that rates of antimicrobial
resistance continue to increase despite a distinct lack of
new antimicrobial agents currently in development.
In the last decade, the emergence of multidrug-
resistant (MDR) bacteria, such as extended-spectrum
beta-lactamase (ESBL)-producing Enterobacteriaceae,
Pseudomonas aeruginosa, Acinetobacter baumannii,
Vancomycin-resistant Enterococcus, and Methicillin-
resistant Staphylococcus aureus, has become a press-
ing issue in the treatment of intra-abdominal
infections.
The increasing emergence of multidrug-resistant bac-
teria combined with a scant pipeline of new antibiotics
to combat these infections (which is particularly discon-
certing for infections by gram-negative microorganisms)
has been documented in a recent report by the Eur-
opean Antimicrobial Resistance Surveillance System
[25].
In the specific context of intra-abdominal infections,
the main resistance problem is posed by ESBL-produ-
cing Enterobacteriaceae, which are commonly identified
in community-acquired infections.
The recent and rapid spread of carbapenemases in
Klebsiella pneumoniae (KPC) has become an important
concern when administering antimicrobial therapy in
hospitals worldwide. Scrupulous optimization of the use
of carbapenems based on indication and exposure is of
utmost importance [26].
Samples obtained from intra-abdominal surgery or
interventional drainage procedures should be cultured;
these samples should be of sufficient volume (at least 1
mL of fluid or tissue, preferably more) and should be
sent to the laboratory for detailed analysis using an
appropriate transport system.
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Aim
The purpose of the study is to describe the clinical,
microbiological, and treatment profiles of community-
acquired and healthcare-acquired complicated intra-
abdominal infections (IAIs) in Europe.
Study population
This prospective multicenter observational study will be
performed in various European medical institutions over
a 6-month period (January-June 2012). Patients under-
going surgery or interventional drainage to address com-
plicated IAI, or patients who have yieded positive
microbiological cultures upon postoperative drainage
(intra-abdominal samples taken from surgery or drai-
nage) will be included in the database. Patients with
pancreatitis, primary peritonitis from cirrhosis, or ascites
will not be included in the study.
Study design
This observational study will not attempt to change or
modify the laboratory or clinical practices of the partici-
pating physicians, and neither informed consent nor for-
mal approval by an Ethics Committee will be required.
The study will meet and abide by the standards out-
lined in the Declaration of Helsinki and Good Epide-
miological Practices.
Data collection
In each center, the coordinator will collect and compile
data in an online case report system.
These data will include the following: (i) patient and
disease characteristics, i.e., demographic data, type of
infection (community- or healthcare-acquired), severity
criteria, previous curative antibiotic therapy administerd
in the 7 days preceding surgery; (ii) origin of infection
and surgical procedures performed; and (iii) microbiolo-
gical data, i.e., identification of bacteria and microorga-
nismal pathogens within the peritoneal fluid, the
presence of yeasts (if applicable), and the antibiotic sus-
ceptibilities of bacterial isolates.
Statistical analysis
Following data entry into a computerized database, the
results will be expressed as standard statistical metrics:
median (range), mean ± standard deviation for continu-
ous variables, and the number of patients (with the cor-
responding percentages) for other qualitative variables.
The primary endpoints will include
￿ Clinical profiles of intra-abdominal infections
￿ Epidemiological profiles (the epidemiology of the
microorganisms isolated from intra-abdominal sam-
ples and these organisms’ resistance to antibiotics)
￿ Management profiles
Comparisons will be performed using the Student’s t-
test, c
2 analysis, or the Kruskall-Wallis/Wilcoxon tests,
as dictated by the natural parameters of the data in
question. Statistical significance will be defined as a P-
value less than 0.05 (P < 0.05). Multivariate analysis will
be carried out by means of stepwise logistic regressions
in order to assess the predictive factors of mortality dur-
ing hospitalization. Adjusted odds ratios (OR) and their
95% confidence intervals (CI) will also be included.
Inclusion Criteria
Patients undergoing surgery or interventional drainage
to address complicated IAI, or patients who have yieded
positive microbiological cultures upon postoperative
drainage (intra-abdominal samples taken from surgery
or drainage) will be included.
Exclusion Criteria
Patients with pancreatitis and primary peritonitis will be
excluded.
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